东亚妇科瘤学试验小组 (EAGOT):创立历史和未来的前景
Takayuki Enomoto1, Aikou Okamoto2, Jae-Hoon Kim3
1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan. tenomoto821@gmail.com.
Journal of gynecologic oncology
|August 18, 2023
概括
东亚妇科瘤试验小组 (EAGOT) 成立,以解决亚洲人群中有限的妇科癌症数据. 该网络旨在通过合作的国际临床试验,改善亚洲妇女的治疗标准和治疗结果.
科学领域:
- 妇科瘤学 妇科瘤学
- 临床试验 临床试验
- 瘤学研究研究
背景情况:
- 在妇科癌症的结果中存在显著的种族和地区差异.
- 大多数大规模的临床试验都在西方国家进行,对亚洲人口的数据有限.
- 亚洲妇女占全球人口的一半以上,但在癌症研究中数据不足.
研究的目的:
- 建立东亚妇科瘤试验小组 (EAGOT),在亚洲建立一个全球临床试验网络.
- 开展国际临床试验,专注于亚洲妇女的妇科癌症.
- 提供优化的治疗策略,改善亚洲妇女患有妇科癌症的预后.
主要方法:
- 2021年11月19日,由四个领先的东亚瘤学团体 (日本,韩国,台湾,中国) 组成EAGOT.
- 设立专门委员会:宫癌,子宫体癌,卵巢癌和转化研究.
- 启动讨论新的协作临床试验和监管流程的协调.
主要成果:
- EAGOT是亚洲最大的妇科癌症医疗保健/研究创新网络.
- 第一次EAGOT年度会议于2023年5月25日至27日在日本尼加塔成功举行.
- 目前正在就合作试验和成员国监管协调进行讨论.
结论:
- 在亚洲,EAGOT将作为一个建立护理标准和制定妇科癌症指南的平台.
- 试验的协调,药物批准和适用范围的扩大预计将提高治疗疗效.
- 该倡议旨在在不久的将来在亚洲地区显著改善妇科癌症的预后.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


